Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Wednesday December 15, 2021 | Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update |
Thursday December 02, 2021 | Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th |
Tuesday November 09, 2021 | ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER |
Thursday October 21, 2021 | Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted Infections |
Monday October 18, 2021 | HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS |
Tuesday October 12, 2021 | Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update |
Tuesday September 28, 2021 | Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th |
Thursday September 02, 2021 | ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE |
Tuesday July 20, 2021 | ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 |
Tuesday June 15, 2021 | Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel |
Wednesday June 09, 2021 | Enzo Biochem Reports Third Quarter Fiscal 2021 Results |
Tuesday June 01, 2021 | Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9 |
Wednesday April 21, 2021 | Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization |
Wednesday March 17, 2021 | ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM |
Monday March 15, 2021 | Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates |
Thursday March 04, 2021 | Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference |
Tuesday March 02, 2021 | Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants |
Monday March 01, 2021 | Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15 |
Wednesday February 03, 2021 | Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin |
Wednesday January 20, 2021 | ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES |
Tuesday January 05, 2021 | ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT |
Monday January 04, 2021 | ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 |